Lorand-Metze I - Search Results

1

No contribution of GSTM1 and GSTT1 null genotypes to the risk of neutropenia due to benzene exposure in Southeastern Brazil.

Lima CS, Lourenço GJ, Lorand-Metze I, Nascimento H, Saad ST, Costa FF. Lima CS, et al. Genet Mol Biol. 2009 Oct;32(4):709-11. doi: 10.1590/S1415-47572009005000067. Epub 2009 Dec 1. Genet Mol Biol. 2009. PMID: 21637441 Free PMC article.

2

The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.

Saad ST, Vassallo J, Arruda VA, Lorand-Metze I. Saad ST, et al. Pathologica. 1994 Feb;86(1):47-51. Pathologica. 1994. PMID: 8072801

3

N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.

De Melo MB, Lorand-Metze I, Lima CS, Saad ST, Costa FF. De Melo MB, et al. Leuk Lymphoma. 1997 Jan;24(3-4):309-17. doi: 10.3109/10428199709039018. Leuk Lymphoma. 1997. PMID: 9156660

4

The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.

Lima CS, Vassalo J, Lorand-Metze I, Bechelli AP, Souza CA. Lima CS, et al. Haematologia (Budap). 1997;28(2):85-95. Haematologia (Budap). 1997. PMID: 9283908

5

Lymphoblastic transformation of myelodysplastic syndrome.

Lima CS, de Souza CA, Cardinalli IA, Lorand-Metze I. Lima CS, et al. Sao Paulo Med J. 1997 Jul-Aug;115(4):1508-12. doi: 10.1590/s1516-31801997000400009. Sao Paulo Med J. 1997. PMID: 9595816

6

Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients.

Melo MB, Costa FF, Saad ST, Lorand-Metze I, Bordin S, Ahmad NN. Melo MB, et al. Leuk Res. 1998 Sep;22(9):787-92. doi: 10.1016/s0145-2126(98)00047-2. Leuk Res. 1998. PMID: 9716009

7

The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.

Vigorito AC, Lorand-Metze I, Chauffaile ML, Costa FF, Saad ST. Vigorito AC, et al. Haematologia (Budap). 1998;29(2):123-32. Haematologia (Budap). 1998. PMID: 9728804

8

Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders.

Lorand-Metze I, Santiago GF, Lima CS, Zanardi VA, Torriani M. Lorand-Metze I, et al. Clin Radiol. 2001 Feb;56(2):107-10. doi: 10.1053/crad.2000.0570. Clin Radiol. 2001. PMID: 11222066

9

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.

Pagnano KB, Vassallo J, Lorand-Metze I, Costa FF, Saad ST. Pagnano KB, et al. Am J Hematol. 2001 Jun;67(2):84-92. doi: 10.1002/ajh.1084. Am J Hematol. 2001. PMID: 11343379 Free article.

10

Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects.

Arruda VR, Lima CS, Grignoli CR, de Melo MB, Lorand-Metze I, Alberto FL, Saad ST, Costa FF. Arruda VR, et al. Eur J Haematol. 2001 Jun;66(6):383-8. doi: 10.1034/j.1600-0609.2001.066006383.x. Eur J Haematol. 2001. PMID: 11488937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters